VKTX- VK2809 in NASH should read out ph2a 52 week biopsy (Fibrosis and NASH Resolution) data very soon. I'm modifying my best guess of when to be tomorrow Wednesday April 24th after the close to coincide with the VKTX earnings release.
Previously Viking readout 12 week top line data that was considerably better than MDGL rezdiffra (resmetirom). I expect VK2809 data to again be better than rezdiffra.
Market Data 
Markets 
AI
